Tripos Shares Slide 10 Percent After Q2 Revenues Decline and Profit Slips to Loss | GenomeWeb
NEW YORK (GenomeWeb News) – Tripos said today that second-quarter revenues declined 33 percent despite a 23 percent revenue growth in its discovery informatics businesses.
Shares in the company were down 10 percent, or $.20, at $1.75 in mid-afternoon trading today on the news.
Receipts for the second quarter dropped to $8.9 million from $13 million in the same quarter last year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.